We are investigating the safety and effectiveness of a new combination therapy for patients with advanced rare cancers that have not responded to previous treatments. This trial includes several types of rare cancers, aiming to find better treatment options.
Health conditions and diseases that the clinical trial is designed to study and treat.
This clinical trial focuses on adult patients with five rare cancers: Peritoneal Mesothelioma, Gestational Trophoblastic Tumors, Thymomas and Thymic Carcinomas, Anaplastic Thyroid Carcinomas, and Gastroenteropancreatic Neuroendocrine Tumors. These cancers are often advanced or metastatic and have shown resistance to standard treatments.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.